Search Results - "Hommes, Otto R"

Refine Results
  1. 1
  2. 2

    Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study by Comi, Giancarlo, Filippi, Massimo, Barkhof, Frederik, Durelli, Luca, Edan, Gilles, Fernández, Oscar, Hartung, Hans-Peter, Seeldrayers, Pierrette, Sørensen, Per Soelberg, Rovaris, Marco, Martinelli, Vittorio, Hommes, Otto R

    Published in The Lancet (British edition) (19-05-2001)
    “…Interferon beta reduces activity in multiple sclerosis as measured clinically and by magnetic resonance imaging (MRI). We assessed the effect of interferon…”
    Get full text
    Journal Article
  3. 3

    Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial by Hommes, Otto R, Sørensen, Per S, Fazekas, Franz, Enriquez, Monika Maas, Koelmel, Hans W, Fernandez, Oscar, Pozzilli, Carlo, O'Connor, Paul

    Published in The Lancet (British edition) (25-09-2004)
    “…Several double-blind placebo-controlled trials of relapsing-remitting multiple sclerosis have shown beneficial effects of intravenous immunoglobulin (IVIG) on…”
    Get full text
    Journal Article
  4. 4

    Intravenous immunoglobulin in MS: Promise or failure? by Fazekas, Franz, Strasser-Fuchs, Siegrid, Hommes, Otto R

    Published in Journal of the neurological sciences (15-08-2007)
    “…Abstract There is an established role for intravenous immunoglobulin (IVIG) in the treatment of certain neurologic autoimmune disorders which affect the…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis by Jongen, Peter J H, Lycklama a Nijeholt, Geert, Lamers, Karel J B, Doesburg, Wim H, Barkhof, Frederik, Lemmens, Wim A J G, Klasen, Ina S, Hommes, Otto R

    Published in European neurology (01-01-2007)
    “…In multiple sclerosis intrathecal IgM synthesis correlates with an unfavourable disease course. Whether this reflects a pathogenic role of IgM, possibly in…”
    Get more information
    Journal Article
  6. 6

    European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis by Filippi, Massimo, Rocca, Maria A, Pagani, Elisabetta, Iannucci, Giuseppe, Sormani, Maria Pia, Fazekas, Franz, Ropele, Stefan, Hommes, Otto R, Comi, Giancarlo

    Published in Archives of neurology (Chicago) (01-09-2004)
    “…Magnetization transfer magnetic resonance imaging (MT MRI) can provide in vivo markers reflecting the severity of multiple sclerosis-related brain damage…”
    Get more information
    Journal Article
  7. 7

    Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis by Jongen, Peter J H, Lamers, Karel J B, Doesburg, Wim H, Lemmens, Wim A J G, Hommes, Otto R

    “…OBJECTIVES To find whether CSF analysis may differentiate between relapsing-remitting and secondary progressive multiple sclerosis. METHODS In 17 patients with…”
    Get full text
    Journal Article
  8. 8

    Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional study by van Walderveen, M A, Barkhof, F, Tas, M W, Polman, C, Frequin, S T, Hommes, O R, Thompson, A J, Valk, J

    Published in European neurology (01-08-1998)
    “…To substantiate differences in magnetic resonance (MR) patterns in clinical subgroups of multiple sclerosis (MS), we analyzed T2-weighted MR images of a large…”
    Get more information
    Journal Article
  9. 9

    The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects by Vercoulen, J H, Hommes, O R, Swanink, C M, Jongen, P J, Fennis, J F, Galama, J M, van der Meer, J W, Bleijenberg, G

    Published in Archives of neurology (Chicago) (01-07-1996)
    “…To provide a multidimensional characterization of fatigue in patients with multiple sclerosis (MS). Cross-sectional design. Fifty patients with clinically…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis by Koldewijn, E L, Hommes, O R, Lemmens, W A, Debruyne, F M, van Kerrebroeck, P E

    Published in The Journal of urology (01-07-1995)
    “…Multiple sclerosis affects the lower urinary tract in many patients. The relationship between lower urinary tract abnormalities and disease-related parameters…”
    Get more information
    Journal Article
  12. 12

    Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis by BARKHOF, F, HOMMES, O. R, SCHELTENS, P, VALK, J

    Published in Neurology (01-08-1991)
    “…In 12 patients with definite multiple sclerosis who received a total of 21 courses of high-dose (1 gram daily for 10 consecutive days) intravenous…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis by van Engelen, B G, Miller, D J, Pavelko, K D, Hommes, O R, Rodriguez, M

    “…Spontaneous remyelination occurs in experimental models of demyelination and in patients with multiple sclerosis, although to a limited extent. This enables…”
    Get full text
    Journal Article
  16. 16

    Evidence for early lower urinary tract dysfunction in clinically silent multiple sclerosis by Bemelmans, B L, Hommes, O R, Van Kerrebroeck, P E, Lemmens, W A, Doesburg, W H, Debruyne, F M

    Published in The Journal of urology (01-06-1991)
    “…The occurrence of micturition complaints as late sequelae of multiple sclerosis is well studied and documented. However, no reports exist on urologically…”
    Get more information
    Journal Article
  17. 17

    Comparison of two MR sequences for the detection of multiple sclerosis lesions in the spinal cord by Lycklama a Nijeholt, GJ, Barkhof, F, Castelijns, JA, van Waesberghe, JH, Valk, J, Jongen, PJ, Hommes, OR

    Published in American journal of neuroradiology : AJNR (01-09-1996)
    “…To compare cardiac-triggered dual-echo spin-echo and magnetization transfer-prepared gradient-echo (MT-GE) MR imaging in the detection of multiple sclerosis…”
    Get full text
    Journal Article
  18. 18

    The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis by Frequin, S T, Barkhof, F, Lamers, K J, Hommes, O R

    Published in Journal of neuroimmunology (01-10-1992)
    “…Blood-brain barrier (BBB) disruption is probably the first event in the lesion development in multiple sclerosis (MS). This stage can be visualized by…”
    Get more information
    Journal Article
  19. 19

    Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone by FREQUIN, S. T. F. M, WEVERS, R. A, BRAAM, M, BARKHOF, F, HOMMES, O. R

    Published in Journal of neurology (01-05-1993)
    “…Twenty-one patients (15 women, 6 men) with definite multiple sclerosis (MS) were treated with 1000 mg intravenous methylprednisolone-succinate (MP) daily for…”
    Get full text
    Journal Article
  20. 20

    Discriminative power of visual evoked potential characteristics in multiple sclerosis by CUYPERS, M. H. M, DICKSON, K, PINCKERS, A. J. L. G, THIJSSEN, J. M, HOMMES, O. R

    Published in Documenta ophthalmologica (01-01-1995)
    “…To investigate the discriminative power of pattern-reversal visual evoked potential characteristics (peak latencies and amplitude) and to test whether the…”
    Get full text
    Journal Article